Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5-Reference-Cited by-同舟云学术

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5

Published:2022-07-07 Issue:1 Volume:387 Page:86-88
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Hachmann Nicole P.¹^ORCID,Miller Jessica¹,Collier Ai-ris Y.¹^ORCID,Ventura John D.¹,Yu Jingyou¹,Rowe Marjorie¹,Bondzie Esther A.¹,Powers Olivia¹,Surve Nehalee¹,Hall Kevin¹,Barouch Dan H.¹

Affiliation:

1. Beth Israel Deaconess Medical Center, Boston, MA

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMc2206576

Reference5 articles.

1. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

2. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

3. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

4. Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

5. Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Cited by 491 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the inhibitory effects of some secondary amines, thioureas and 1,3-dimethyluracil conjugates of (-)-cytisine and thermopsine on the RNA-dependent RNA polymerase of SARS-CoV-1 and SARS-CoV-2;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Science-based exit from stringent countermeasures against COVID-19: Mortality prediction using immune landscape between 2021 and 2022 in Japan;Vaccine: X;2024-10

3. Exploring early COVID-19 therapies, variants, and viral clearance dynamics: Insights from a high-risk outpatients study;Diagnostic Microbiology and Infectious Disease;2024-10

4. Insights from an observational translational research program during the COVID-19 pandemic: Four years of experience;Vaccine;2024-10

5. A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children;Expert Review of Vaccines;2024-09-09